The Dementia Action Alliance (DAA) has issued a call to action to gain support from patients, carers and clinicians to ensure that all people with dementia who are receiving antipsychotic drugs should receive a clinical review from their doctor to ensure that their care is compliant with current best practice and guidelines and that alternatives to medication have been considered by 31 March 2012.
The DAA represents over 40 organisations who are committed to transforming the quality of life of people living with dementia in the UK including the Alzheimer's Society, the NHS Institute for Innovation and Improvement and the National Institute for Health and Clinical Excellence.
Action: Clinicians should be aware of this campaign. Media coverage may generate queries from patients and carers which will present an opportunity to offer a clinical review.
|« Top Tips for Safer Prescribing||MeReC Bulletin - Improving outcomes in type 2 diabetes »|